SC Vaccine Supplier Starts Upstate Production In May

/in , , /by

As part of the company’s $114 million global expansion at six facilities in Europe and the United States announced in January, Pall Corp. selected Spartanburg as its newest biopharma manufacturing base. The $30.2 million investment at the 816 Berry Shoals Road site in Duncan, formerly known as “Project Stone,” is expected to create 425 jobs and start production in May, according to a news release.

For the full story, click here.